Position history for Avoro Capital Advisors LLC's holdings in TAYSHA GENE THERAPIES INC
Avoro Capital Advisors LLC holds 21.7M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $97M as of 2026-Q1. TSHA represents 1.0% of Avoro Capital Advisors LLC's portfolio.
Current Value
$97M
Current Shares
21.7M
Total Value Change
+$55.2M
Total Shares Change
+3.1M
Other major holders of TSHA: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., GOLDMAN SACHS GROUP INC
Unchanged |
| 21.7M |
0.0% |
| $97M |
| 1.0% |
| $4.53 |
0 |
| 2025-Q4 | Unchanged | 21.7M | 0.0% | $119.4M | 1.2% | $5.66 | 0 |
| 2025-Q3 | Unchanged | 21.7M | 0.0% | $71M | 0.9% | $3.16 | 0 |
| 2025-Q2 | Increased | 21.7M | +8.5% | $50.1M | 0.9% | $2.38 | 46 |
| 2025-Q1 | Unchanged | 20M | 0.0% | $27.8M | 0.4% | $1.93 | 0 |
| 2024-Q4 | Increased | 20M | +7.2% | $34.6M | 0.5% | $1.73 | 38 |
| 2024-Q3 | Unchanged | 18.7M | 0.0% | $37.5M | 0.5% | $2.07 | 0 |
| 2024-Q2 | Unchanged | 18.7M | 0.0% | $41.8M | 0.6% | $2.24 | 0 |